Disufenton

DB17298InvestigationalSmall molecule

Disufenton: Overview.

Chemical structure of Disufenton
Formula / weight
C11H15NO7S2 · 337.36 g/mol (avg)
Also known as
1,3-benzenedisulfonic acid, 4-(((1,1-dimethylethyl)oxidoimino)methyl)- · 2,4-disulfonyl-.alpha.-phenyl-tert-butylnitrone · 4-(((1,1-dimethylethyl)imino)methyl)benzene-1,3-disulfonate n-oxide · 4-(((1,1-dimethylethyl)imino)methyl)benzene-1,3-disulphonate n-oxide · 4-(((1,1-dimethylethyl)oxidoimino)methyl)-1,3-benzenedisulfonic acid

Resolves to

Compound
UNII797K01YF1MCAS168021-77-0ChEMBLCHEMBL1206050
Structure
InChIKeyOVTCHWSLKGENKP-GHXNOFRVSA-NSMILESCC(C)(C)[N+](\[O-])=C\C1=C(C=C(C=C1)S(O)(=O)=O)S(O)(=O)=O
Targets
Q8IWU5SULF2

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
10Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Disufenton, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In